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Abstract: Black band disease (BBD) of corals is a cyanobacteria-dominated polymicrobial 
disease that contains diverse populations of heterotrophic bacteria. It is one of the most 
destructive of coral diseases and is found globally on tropical and sub-tropical reefs. We 
assessed ten strains of BBD cyanobacteria, and ten strains of cyanobacteria isolated from 
other marine sources, for their antibacterial effect on growth of heterotrophic bacteria 
isolated from BBD, from the surface mucopolysaccharide layer (SML) of healthy corals, 
and three known bacterial coral pathogens. Assays were conducted using two methods:   
co-cultivation of cyanobacterial and bacterial isolates, and exposure of test bacteria to 
(hydrophilic and lipophilic) cyanobacterial cell extracts. During co-cultivation, 15 of the   
20 cyanobacterial strains tested had antibacterial activity against at least one of the test 
bacterial strains. Inhibition was significantly higher for BBD cyanobacteria when compared 
to other marine cyanobacteria. Lipophilic extracts were more active than co-cultivation 
(extracts of 18 of the 20 strains were active) while hydrophilic extracts had very limited 
activity. In some cases co-cultivation resulted in stimulation of BBD and SML bacterial 
growth. Our results suggest that BBD cyanobacteria are involved in structuring the complex 
polymicrobial BBD microbial community by production of antimicrobial compounds.  
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1. Introduction 
Black band disease (BBD) of corals is known to contribute to the degradation of coral reefs in the 
wider Caribbean [1], the Indo-Pacific [2], including the Great Barrier Reef [3], and the Red Sea [4]. It 
has been reported to affect 70 species of corals, including both scleractinians and gorgonians [2], and 
can cause whole colony mortality by rapid tissue lysis. The disease often targets the ecologically 
important reef-framework coral species.  
In appearance, BBD is a dark, well-defined cyanobacterial mat that forms a band, which moves 
across the coral surface, degrading coral tissue and leaving behind bare coral skeleton. It is a 
polymicrobial disease dominated by non-heterocystous filamentous cyanobacteria and contains 
populations of sulfate-reducing bacteria, sulfide-oxidizing bacteria, and heterotrophic bacteria. The 
BBD microbial community is highly diverse as revealed through microscopy [5,6] and, in particular, 
molecular biological methods [7–10].  
It has been proposed that some of the BBD microbial diversity may be due to incorporation of coral 
surface mucopolysaccharide layer (SML) bacteria into the BBD population [8]. In turn, the presence of 
disease may affect the SML bacterial community. Previous studies of coral-associated bacteria 
revealed that apparently healthy corals contain less diverse bacterial communities than the healthy 
areas of diseased corals, and that the compositions of the two populations are different [7]. While it is 
known that coral-associated bacteria are present in coral tissue and skeleton as well as the SML, 
studies of the composition of coral-associated bacterial communities have focused on those present in 
coral tissue [7,8,11–15], with fewer studies targeting those within the coral SML [10,15,16]. The 
results of these studies, in general, indicate that members of the gamma- and alpha-proteobacteria 
dominate coral-associated bacterial populations.  
The coral probiotic hypothesis [11] proposes that coral resistance to disease can be promoted by 
coral-associated bacteria, which prevent colonization by potential pathogens or outcompete pathogens 
which may settle on coral. The protective mechanism of coral probiotic bacteria is proposed to include 
antibacterial activity, and to date there have been a number of studies aimed at demonstrating that 
corals and their associated bacteria possess such properties [16–22]. Koh [18] showed that the alcohol 
extract of a large percentage of coral samples had antibacterial activity against a number of heterotrophic 
bacteria and cyanobacteria, while results obtained by Kim [20] demonstrated antibacterial activity for 
both polar and non-polar (coral-derived) fractions with higher activity associated with non-polar 
fractions. In both studies the extracts were prepared from the coral holobiont (the coral animal, 
endosymbiotic zooxanthellae, and coral-associated bacteria), and the origin of the active compounds 
was not determined. Ritchie [16] found antibacterial activity among the microbial community 
associated with the mucus of healthy corals.  
Deciphering the relationships among and between the bacterial members of the complex BBD 
microbial consortium could provide insight into the etiology of this polymicrobial disease. Since 
cyanobacteria are the dominant component of BBD in terms of biomass, we selected this group of Mar. Drugs 2011, 9  
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microorganisms to investigate their ability to inhibit growth of both BBD and (healthy) coral SML 
bacterial isolates. In this way, we hypothesize that cyanobacteria may structure the complex BBD 
microbial community. We also investigate, for comparison, the antibacterial activity of sub-tropical 
marine cyanobacteria from other marine sources. This study assesses the potential of marine 
cyanobacteria as a source for novel antibacterial agents that could potentially be applied in human health. 
2. Results  
2.1. Inhibition of BBD and SML Bacteria during Co-Cultivation with Cyanobacteria  
Co-cultivation of BBD and SML bacteria with cyanobacteria revealed that, of the 20 cyanobacterial 
strains tested, 15 had antibacterial activity against at least one of the target bacteria. Nine of the BBD 
cyanobacterial strains, and six of the other marine cyanobacterial strains, exhibited activity (Figure 1).  
Figure 1. Percent of black band disease (BBD) and surface mucopolysaccharide layer 
(SML) bacteria inhibited by individual cyanobacterial strains in co-cultivation experiments. 
(A) BBD cyanobacteria; (B) other marine cyanobacteria. Note different scales on Y axes. 
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Seven BBD cyanobacteria were active against both BBD and SML bacteria, while only three of the 
other marine cyanobacteria were active against both groups. Each of the active cyanobacterial strains 
from both sources was active against SML bacteria. In contrast, only seven of the nine active BBD and 
three of the six active other marine cyanobacterial strains were active against BBD bacteria. Overall, 
co-cultivation with BBD cyanobacteria resulted in a higher, statistically significant number of 
inhibitions than other marine cyanobacteria (Figure 2).  
Figure 2. Inhibition of BBD and SML bacteria by BBD and other marine cyanobacteria in 
the co-cultivation experiment. Cyanobacteria from BBD inhibited significantly more 
bacteria from both BBD (t-test: P = 0.026) and SML (Mann-Whitney test: P = 0.016) than 
other marine cyanobacteria. Error bars = SD (non-transformed data). Asterisks indicate 
statistically significant results.  
 
2.2. Interactions between Individual Bacterial and Cyanobacterial Strains 
The activity of individual cyanobacterial strains against individual bacterial strains is summarized 
in Table 1. This data set includes, in addition to antibacterial activity, cases in which stimulation of 
bacterial growth was observed (strain designations bolded). The results of experiments examining both 
co-cultivation and exposure to lipophilic extract are summarized. Strain abbreviations designated in 
Table 2 as B (BBD), S (SML) and P (known pathogen) were used in Table 1 for ease of comparison of 
results for these three categories of test bacteria. Mar. Drugs 2011, 9  
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Table 1. Effect (antibacterial activity and stimulation of growth) of BBD and other marine 
cyanobacteria on coral-associated bacteria. Stimulation is indicated in bold. Strain 
designations are defined in Table 2. 
Cyanobacteria 
Bacterial strains inhibited or 
stimulated by co-cultivation 
Bacterial strains inhibited  
by lipophilic extracts 
BBD Isolates    
BBD 1991  Geitlerinema  B3, B5, B6, S1, S3, S5, S7, S9, S11  B1, B2, B5, B9, B10, P2, P2, S2, S8, S12 
HS 217  Geitlerinema  B3, B6, S5, S6, S7, S8, S13  P1 
HS 223  Geitlerinema  B1, B3, B5, B6, B8, P3, S1, S3, S4, S6, 
S7, S9, S13 
B1, B2, B3, B5, B9, B10, P1, P2, S2, S3 
W-1   Geitlerinema  B6, S6, S7  B9, B10, S9, S10 
FLK BBD1  Leptolyngbya  No effect  B1, B2, B5, B9, P1, P2, S3, S6, S8 
P2b-2  Leptolyngbya  B1, B3, B6, S3, S4, S5, S6, S7, S11, S13 B5, B9, S1, S4, S7, S9, S10 
102a-1  Leptolyngbya  B1, B6, S3, S7  B4 
102d-1  Leptolyngbya  S2, S9, S13  B4 
96-2  Leptolyngbya  B2, B6, S3, S6, S7, S8, S13  No effect 
96-4  Spirulina  S3, S4, S9  B4, S2, S10 
Other marine isolates    
Alg  Leptolyngbya  No effect  B2, B3, B4, B5, B9, P1, P2, S2, S4, S8, S12
10  Leptolyngbya  No effect  B9, P2, S4 
9-1  Leptolyngbya  No effect  B5, B9, P1, S12 
HS 26  Leptolyngbya  No effect  B5, S12 
73-2  Phormidium  B1, S2, S8, S9  B1, B4, B5, P2, S1, S2, S4 
63a-5  Pseudanabaena S6, S7  B5, B10, P2, S4, S9, S10 
63-1  Pseudanabaena S4, S5, S9 No  effect 
72-1  Pseudanabaena B3, S4  B5, B9, B10, P2, S7, S9, S10 
63a-1  Synechococcus  B1, B2, S2, S4, S5, S9, S10   B1, B2, B3, B5, B9, P1, P2, S2, S9 
63a-3  Synechococcus  B1, B2, S5, S9  B5, B9, B10, S7, S9, S12 
Table 2. Bacterial strains used as target organisms for assessment of the effects of growth 
in co-culture with, or exposure to extracts of, BBD and other marine cyanobacteria. 
Strain 
designation 
GenBank closest relative 
Accession No. of 
closest relative 
1 
Strain 
abbreviation 
2 
Strains from BBD    
HS-216-1a  Vibrio harveyi  AY750576 B1 
HS-216-3d  Bacillus megaterium  AJ17381 B2 
HS-217-1a  Bacillus cereus  AY305275 B3 
HS-217-1c  Photobacterium eurosenbergii  AJ842344 B4 
HS-216-4f  Marinobacter sp.  AY196982 B5 
HS-217-2g  Alteromonas sp.  AY626838 B6 
HS-216-4g  Marinobacter aquaeolei  AJ000726 B7 
HS-216-4i  Idiomarina sp.  AB167047 B8 
HS-217-2d  Vibrio harveyi  AY750575 B9 
HS-216-4a  Methylarcula sp.  AJ534208 B10 Mar. Drugs 2011, 9  
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Table 2. Cont. 
Known coral pathogens   
  Aurantimonas coralicida  N/A P1 
  Serratia marcescens  N/A P2 
  Vibrio shiloi  N/A P3 
Strains from healthy corals   
1-1  Vibrio sp.  EU267634 S1 
1-2  Alcanivorax sp.  EU781516 S2 
1-3  Vibrionaceae   EF584057 S3 
1-7  Vibrio sp.  EU267643 S4 
1-8a  Bacillus sp.  EU070391 S5 
1.8b  Bacillus sp.  FJ461465 S6 
1-9  Vibrio harveyi  DQ995240 S7 
1-10  Vibrio sp.  EU267643 S8 
1-11  Vibrio sp.  FJ178079 S9 
1-12  Vibrio sp.  EF100710 S10 
1-13  Vibrio sp.  FJ457416 S11 
1-14  Vibrio sp.  EU276991 S12 
1-16  Vibrio sp.  EF584084 S13 
1 Strains were 99% similar to the GenBank Accession No. listed with the exception of strains 1-1, 1-7 and 1-10 (100%) 
and HS-216-4a (96%); 
2 Strain abbreviations used in Table 1. Abbreviations indicate source: B = BBD, S = SML, and  
P = known pathogen. N/A = not applicable as known cultures of these strains were used. 
Of the 460 combinations tested (20 cyanobacterial strains × 23 bacterial strains), co-cultivation with 
cyanobacteria resulted in inhibition in 11% of cyanobacteria/BBD bacteria tests and 18% of 
cyanobacteria/SML bacteria tests, with stimulation observed for 1% and 4% respectively (Table 1). In 
many cases the same bacterial strain was inhibited by different cyanobacteria. Five of the bacterial 
isolates tested (four SML and one BBD) exhibited very high sensitivity to co-cultivation with BBD 
cyanobacteria. For example strain B6 (isolate HS-217-2g, identified in GenBank as Alteromonas sp.) 
was inhibited by seven of the 10 BBD cyanobacteria. In contrast, none of the other marine 
cyanobacteria affected growth of this isolate. Of the SML bacterial isolates, strains S3, S6, S7, and S13 
(three Vibrio sp. and one Bacillus—see Table 2) were each inhibited during co-cultivation with five to 
seven BBD cyanobacteria (Table 1). 
2.3. Activity of Cyanobacterial Extracts 
Exposure of test BBD and SML bacteria to lipophilic cyanobacterial extracts (Table 1) resulted in 
overall higher inhibition when compared to co-cultivation. There were no cases of growth stimulation. 
Lipophilic extracts of nine of the 10 of both BBD and other marine cyanobacteria were active (18 of 
the 20 strains). Overall, 23% of BBD bacteria and 26% of SML bacteria exhibited inhibition of growth 
after exposure to lipophilic extracts. There was no significant difference in the activity of BBD and 
other marine cyanobacteria lipophilic extracts against the BBD and SML bacteria tested (Figure 3). Mar. Drugs 2011, 9  
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Figure 3. Inhibition of BBD and SML bacteria by lipophilic extracts from BBD and other 
marine cyanobacteria. There were no significant differences between these two groups of 
cyanobacteria. Error bars = SD (non-transformed data). 
 
The lipophilic extracts exhibited much more antimicrobial activity than the hydrophilic extracts, 
which in most cases did not have any activity (data not shown). Hydrophilic extracts of only three of 
the nine BBD cyanobacteria tested were active, with two strains inhibiting one of the 10 BBD strains 
(B1 and B7) and the third inhibiting one SML strain (S8). Hydrophilic extracts of other marine 
cyanobacteria did not inhibit any BBD strains, although four of these other marine cyanobacteria 
(seven of 10 tested) did inhibit SML bacteria. Of these, three cyanobacteria inhibited one strain and 
one cyanobacterium inhibited two strains, with three strains active against S12. 
2.4. Activity of Extracts vs. Co-Cultivation with SML and BBD Bacteria  
In Table 1, it can be seen that members of all cyanobacterial genera tested exhibited antibacterial 
activity, either during co-cultivation or exposure to lipophyllic extracts. The antibacterial activities of 
cyanobacterial extracts did not coincide with the results of co-cultivation experiments using the same 
cyanobacterial strains. The most dramatic example is the case of the non-BBD Leptolyngbya isolates, 
in which none of the co-cultivation experiments yielded any effect whereas lipophilic extracts 
inhibited nine strains of BBD bacteria and seven of SML bacteria.  
2.5. Antibacterial Activity against Known Coral Pathogens 
Only one of the three known coral pathogens tested, Vibrio shiloi (P3 in Table 1), was inhibited by 
co-cultivation with cyanobacteria, and only one of the 20 cyanobacterial strains tested (BBD 
Geitlerinema HS 223) elicited this result. None of the cyanobacterial extracts elicited growth inhibition 
of Vibrio shiloi, and no assay (co-cultivation or extract) elicited stimulation of this pathogen. The other Mar. Drugs 2011, 9  
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two known coral pathogens tested, Aurantimonas coralicida and Serratia marcescens, were affected 
(inhibition only) by lipophilic cyanobacterial extracts (Table 1), with no effect observed for the 
hydrophilic extracts tested (not shown). Lipophilic extracts of four of the BBD cyanobacterial strains 
and three other marine cyanobacterial strains inhibited A. coralicida, while lipophilic extracts of three 
BBD cyanobacteria and six other marine cyanobacteria inhibited S. marcescens (Table 1). Overall 
there were 16 cases of inhibition of both pathogens, with five of the cyanobacterial strains (including 
both BBD and other marine cyanobacteria) inhibiting both A. coralicida and S. marcescens (P1 and  
P2 in Table 1).  
3. Discussion 
In recent years the study of coral-associated microorganisms has greatly expanded, with a focus on 
the role of such microorganisms in coral health and disease. A number of these studies have 
documented antibacterial activity among and between coral-associated bacteria [16,21], and also 
antimicrobial activity of corals themselves [16,22].  
Cyanobacteria are well known to produce antibacterial compounds [23–26] and are known to be 
associated with corals [8]. However, little work has been done to assess the antibacterial activity of 
coral-associated cyanobacteria, or, for that matter, cyanobacteria in other marine environments. In this 
work we assessed the activity of marine cyanobacteria on growth of coral-associated bacteria using 
two different methods: co-cultivation in which cyanobacterial metabolites were allowed to diffuse into 
agar (without breaking their cell walls), and use of extracts prepared from equal amounts of dried 
cyanobacterial culture biomass. Our results revealed that co-cultivation of cyanobacteria with BBD or 
SML heterotrophic bacteria resulted in 4.8% cases of inhibition of BBD bacteria and 10% cases of 
inhibition of SML bacteria. This result was statistically significant for both BBD and other marine 
cyanobacteria (P < 0.05; see legend of Figure 2).  
Overall, BBD bacteria appear to be more resistant to antibacterial activity of marine cyanobacteria in 
general. This might be expected since BBD bacteria live in close physical contact with cyanobacteria. 
Within the total BBD bacterial/cyanobacterial test cases, 82% of BBD bacteria exhibited resistance. 
However, the 18% that were inhibited were represented by six of the 10 BBD bacterial strains tested. 
This result may be important in that the complex BBD microbial community may require small 
populations of some functional members; from this perspective, regulation of growth of certain 
bacterial members within the organic carbon/nutrient rich BBD environment would be an important 
part of the disease etiology.  
There was a much higher percentage (30% of test cases) of inhibition of SML bacteria by BBD 
cyanobacteria when compared to inhibition of BBD bacteria. This finding suggests that BBD 
cyanobacteria may be capable of eliminating potentially beneficial, protective coral-associated 
bacteria, thus supporting the coral probiotic hypothesis [11]. Alternatively, BBD cyanobacteria may 
eliminate SML bacteria within a developing BBD microbial community to reduce competition. Other 
marine cyanobacteria also showed antibacterial activity in 9% of test cases. Therefore, it can be 
hypothesized that non-pathogenic cyanobacteria present in healthy corals may also provide protection 
against disease-causing microorganisms.  Mar. Drugs 2011, 9  
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We observed, to a lesser extent, stimulation of growth of some bacterial isolates during co-cultivation 
with cyanobacteria, in particular with other marine cyanobacteria. While there were only two cases of 
stimulation by BBD cyanobacteria (both of SML bacteria), there were 10 cases of stimulation by other 
marine cyanobacteria. This is in agreement with the findings of Morrow et al. [27] who reported that 
two marine Lyngbya species stimulated, but did not inhibit, the growth of marine bacteria.  
Antimicrobial activity was found mostly among extracts obtained with non-polar rather than 
hydrophilic solvents, which is in agreement with the findings of others [28]. This can be attributed to 
the fact that lipophilic compounds more easily cross the cell membrane, thus are more likely to exert 
an affect. BBD cyanobacteria appear to produce a variety of antibacterial compounds that are not 
excreted, thus their effect on members of the BBD consortium would be limited. We believe that the 
co-cultivation experiments more closely mimic the ecological conditions within BBD since 
microscopic observations of BBD samples reveal healthy, highly motile cyanobacteria and an absence 
of lysing filaments.  
Comparison of the coral-associated bacterial isolates used in these experiments with a recently 
conducted meta-analysis of 84 BBD bacterial clone libraries [29] revealed that none of our isolates 
was a match to BBD sequences deposited from these sources in GenBank. This is not unusual, as 
pointed out recently in a study of coral-associated bacteria by Rypien et al. [21] that used a 
combination of culture-based and molecular methods. We do note that our test bacteria were 
represented by members of three genera, Marinobacter sp., Alteromonas sp., and Vibrio sp., which 
have been reported in BBD clone libraries [29]. Of these, the BBD Marinobacter isolate used in the 
current study (strain B5) and the Alteromonas isolate (strain B6) were inhibited by two and seven 
strains of BBD cyanobacteria respectively (Table 1). Neither was inhibited by other marine 
cyanobacteria, and neither was stimulated by any (BBD or other marine) cyanobacterial strain tested. 
The Vibrio sp. strains were inhibited to different extents by both BBD and other marine cyanobacteria.  
For the known coral pathogens, co-cultivation in only one of the 60 tests (20 cyanobacteria ×  
3 bacterial pathogens) resulted in inhibition. This result was obtained for the bacterial bleaching 
pathogen Vibrio shiloi. Nissimov et al. [30] found, in an investigation of the antibacterial properties of 
bacteria from coral mucus, that 5.7% of bacterial isolates inhibited Vibrio shiloi. Therefore, if this 
bacterium is responsible for bleaching of corals under certain environmental conditions, as proposed 
by Rosenberg et al. [31], it appears that protection of coral would be not be conferred by 
cyanobacterial members of the coral holobiont, and perhaps not by bacterial members.  
It was surprising that while co-cultivation did not inhibit growth of the other two coral pathogens 
tested (Aurantimonas coralicida and Serratia marcescens) there was inhibition in 27% (16 of 60) of 
the tests conducted using lipophilic cyanobacterial extracts. Therefore cyanobacteria (both BBD and 
other marine) may potentially be involved in protecting corals from these specific pathogens.  
Our results indicate that both pathogenic (BBD) and non-pathogenic marine cyanobacteria can 
affect the growth of coral-associated bacteria, and that while most of this activity is manifested as 
inhibition of growth, growth stimulation also occurs. While we did not, in the present study, identify 
the cyanobacterial compounds responsible for the observed activity, other studies in our laboratory 
suggest that at least some of the activity could be due to the cyanotoxin microcystin. We have 
previously shown that BBD cyanobacteria produce microcystins [32–34] and that freshly collected 
BBD samples contain microcystins [32]. All of the cyanobacteria used in the current study were Mar. Drugs 2011, 9  
 
2098
previously shown to produce microcystin-LR in the laboratory [33,34], with the exception of two 
Leptolyngbya strains that were not tested (strains 96-2 and 9-1; see Table 3). We have also shown that 
exposure of healthy coral fragments to low concentrations (1 μg L
−1) of purified microcystin-LR 
resulted in increased bacterial growth in coral fragments, observed using Scanning Electron 
Microscopy [35]. This observation was investigated by exposing bacterial isolates to three 
concentrations (1, 100 and 500 μg L
−1) of purified microcystin-LR and monitoring growth. These 
experiments were carried out using 24 of the 26 bacteria used in the present study (the two strains not 
tested were SML strains 1-1 and 1-14, both Vibrio spp.). Results were variable, with microcystin 
exposure both inhibiting and stimulating bacterial growth. When comparing the microcystin results with 
the results of the current study, only 17% of the cases of inhibition or stimulation by co-cultivation, and 
23% of the cases of inhibition or stimulation in response to exposure to lipophilic extracts, were recorded 
for strains that responded to microcystin. Separating microcystin effects from other compounds would 
require detailed chemical analyses. Another potential source of the active compounds documented in this 
study consists of bacteria associated with the non-axenic cyanobacterial cultures. However, we deem 
this source to be negligible since all cyanobacteria were grown autotrophically for these experiments, 
thus their biomass would be orders of magnitude higher than the contaminants. Microscopic 
examination of the cyanobacterial cultures did not reveal the presence of bacteria; they could be 
detected only by plating cyanobacteria onto heterotrophic media. 
Table 3. Cyanobacterial isolates investigated, taxonomic identification, location of 
collection, and source of origin. 
Isolate 
Closest 
relative 
Similarity 
% 
GenBank 
access. No. 
Location/Source Reference 
BBD Isolates 
BBD 1991  Geitlerinema 
1  99  DQ151461  Florida Keys, Algae Reef, BBD 
on Montastraea annularis 
[36] 
HS 217  Geitlerinema  99  EF110974  LSI Bahamas, Horseshoe Reef, 
BBD on Siderastrea siderea 
[37] 
 
HS 223  Geitlerinema  99  DQ680351  LSI Bahamas, Horseshoe Reef, 
BBD on Siderastrea siderea 
[37] 
W-1   Geitlerinema  99  EF154084  Florida Keys, Watson’s Reef, 
BBD on Siderastrea siderea  
[37] 
FLK BBD1   Leptolyngbya  98  EF110975  Florida Keys, South Carysfort, 
BBD on Montastraea annularis  
[37] 
P2b-2  Leptolyngbya  98  EF372581  Philippines, BBD on Porites lutea [37] 
102a-1  Leptolyngbya  97  EU743966  Florida Keys, BBD on 
Dendrogyra cylindrus 
[33] 
102d-1  Leptolyngbya 
2  97  EU743968  Florida Keys, BBD on 
Montastraea annularis  
[33] 
96-2  Leptolyngbya 
3,4  N/A  N/A  Florida Keys, BBD on 
Montastraea annularis  
This work 
96-4  Spirulina  93  EU743969  Florida Keys, BBD on 
Montastraea annularis  
[33] Mar. Drugs 2011, 9  
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Table 3. Cont. 
Other marine isolates 
Alg  Leptolyngbya 
3,4  N/A  N/A  Florida Keys, Algae Reef, mat on 
sediment  
[33] 
10  Leptolyngbya  99  FJ232377  Florida Keys, NN Dry Rocks, mat 
on Montastraea cavernosa 
[33] 
9-1  Leptolyngbya 
3,4  N/A  N/A  Florida Keys, Horseshoe reef, mat 
on Colpophyllia natans 
This work 
HS26  Leptolyngbya  N/A  FJ232376  Florida Keys, Horseshoe reef, mat 
on coral away from BBD 
[33] 
73-2  Phormidium  97  EU196366  Gulf of Mexico, plankton  [38] 
63a-5  Pseudanabaena  97  FJ026734  Florida Keys, mat on sediment  [33] 
63-1  Pseudanabaena 
2  98  EU110976  Florida Keys, mat on sediment  [38] 
72-1  Pseudanabaena  98  EU196365  Florida Keys, NN dry rocks, mat 
on Montastraea cavernosa 
[38] 
63a-1  Synechococcus 
2  98  EU743972  Florida Keys, mat on sediment  [33] 
63a-3  Synechococcus  98  EU743971  Florida Keys, mat on sediment  [33] 
1 This strain, identified morphologically as Phormidium was subsequently shown using molecular techniques to belong to 
Geitlerinema; 
2 These strains were not tested using hydrophilic extracts, see text; 
3 Not sequenced; 
4 Identified using 
classical taxonomic criteria because the BLAST search did not provide a species level identification. 
4. Experimental Section  
4.1. Source of Cyanobacterial and Bacterial Isolates 
Table 3 presents the source and identities of the 20 cyanobacteria investigated in this study. Ten 
cyanobacterial strains from BBD, representing members of three cyanobacterial genera, from reefs of 
the Florida Keys, Bahamas, and the Philippines, and ten other marine cyanobacterial strains 
representing four genera from the Gulf of Mexico and reefs of the Florida Keys, were obtained as  
non-axenic uni-algal cultures as previously described [33,37]. The three BBD cyanobacterial genera 
have been detected in multiple BBD mats on different reefs of the Caribbean and the Philipines and 
from different coral host species [37]. From work by our group and others it appears that specific 
cyanobacteria are found in BBD regardless of host or location [7,9,37,39,40] hence our selection   
of cyanobacterial isolates from the different sources. The other marine cyanobacteria included   
mat-forming, filamentous types and planktonic, unicellular types from sub-tropical reef habitats in 
Florida as well as the Gulf of Mexico. All filamentous cyanobacteria were cultured from individual 
trichomes and were uni-algal cultures. Accompanying bacteria were closely associated with the 
cyanobacterial sheaths. Cultures of unicellular cyanobacterial isolates were axenic.  
Heterotrophic bacteria used as test strains were isolated from BBD infections on the host coral 
Siderastrea siderea on Horseshoe Reef, Lee Stocking Island, Bahamas (10 strains), and from the SML 
of apparently healthy colonies of S. siderea on reefs in the Florida Keys (13 strains), summarized in 
Table 2. Unlike BBD cyanobacteria, for which the same 16S rRNA gene sequences are found on 
different coral host species and in different geographical regions [37], BBD-associated heterotrophic 
bacteria have been shown to be region specific [40]. On the other hand, Caribbean coral-associated Mar. Drugs 2011, 9  
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heterotrophic bacteria have been reported to be coral host species specific [13]. Therefore we selected 
test SML bacteria from different colonies of the same coral species (S. siderea) to decrease variability 
based on host specificity. Additionally, three known bacterial coral pathogens were tested. These were 
Aurantimonas coralicida, Serratia marcescens, and Vibrio shiloi, associated with the coral diseases 
white plague type II, white pox, and bacterial bleaching [41–43] respectively, and were available as 
previously isolated laboratory cultures. 
4.2. Field Sampling 
Samples of BBD and the SML of apparently healthy corals were collected, using sterile needleless 
10 mL syringes, while SCUBA diving. After collection, samples were maintained at ambient seawater 
temperature in darkness until return to the lab. Strains of heterotrophic bacteria were isolated into pure 
culture by streaking BBD or SML samples onto Marine Agar (Difco) plates. Inoculated plates were 
incubated at room temperature and colonies with different morphologies were picked and replated to 
purity. Pure cultures were maintained at room temperature on marine agar slants, while cyanobacterial 
cultures were maintained on marine BG11 liquid medium in 125 mL Erlenmeyer flasks at 26 °C, under 
a 12:12 h light:dark fluorescent light regime with an intensity of 20 μE m
−2 s
−1. 
Taxonomic identifications were based on 16S rRNA gene sequencing and BLASTN search for the 
closest relatives in GenBank. Isolation of total genomic DNA, 16S rRNA gene amplification, and 
sequencing were performed as described elsewhere [37,44]. Cyanobacterial strains 96-2, Alg, and 9-1 
were not sequenced and their taxonomic identification was based on morphology [45]. The sequence 
obtained from strain HS26 was most closely related (97% similarity) to an “uncultured cyanobacterium, 
clone Ct-3-39” obtained from coral reef sediments (accession number AM177427 in the GenBank 
database). This strain was also identified using classical methods based on morphology [45]. 
4.3. Co-Cultivation of Cyanobacteria and Heterotrophic Bacteria 
One of the two methods used to assess the effect of the cyanobacterial isolates on growth of 
heterotrophic bacteria was the co-cultivation method [46]. BG11 agar plates were first overgrown with 
a test strain of cyanobacteria, then cut into 7 mm diameter disks which were transferred to empty Petri 
plates. Plates were then overlaid with warm Marine Agar and refrigerated overnight to allow diffusion of 
metabolites from the disk into the surrounding medium. Subsequently, each plate was spread-inoculated 
with one of the test bacteria, each of which had been grown in Marine Broth for 24 h prior to inoculation. 
This procedure was carried out for each combination of cyanobacteria-heterotrophic bacteria strains  
(20 × 26 = 520) and was carried out in triplicate (1560 individual tests). Plates were incubated at 27 °C 
for 48 h after which they were checked for the presence of inhibition zones or enhanced growth 
(stimulation). Antibacterial activity was recorded as positive if the zone of inhibition was equal to or 
greater than 9 mm in diameter.  
4.4. Preparation of Cyanobacterial Extracts 
The second method used to assess cyanobacterial/bacterial interactions was based on testing of 
cyanobacterial cell extracts. To prepare extracts cyanobacteria were grown in 3-L cultures in marine Mar. Drugs 2011, 9  
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BG11 medium [47] at 28 °C and a light intensity of 30 μE m
−2 s
−1. Cultures were aerated with sterile 
air and harvested after four weeks by centrifugation. The collected biomass was freeze dried and kept 
at −20 °C until used for extract preparation as described in [46]. Two types of crude extracts were 
prepared, lipophilic and hydrophilic, from each sample. The biomass (100 mg of freeze dried sample 
for each cyanobacterial culture) was first extracted with chloroform (lipophilic extract), and then with 
30% ethanol (hydrophilic extract). Both extracts were evaporated to dryness, then resuspended in 
absolute ethanol and 30% ethanol, respectively, to produce a final concentration of 1 mg of dry residue 
per mL of solvent.  
4.5. Activity of Cyanobacterial Extracts 
The agar diffusion technique was used to test the effect of cyanobacterial extracts on the growth of 
bacterial isolates. Wells in Marine Agar plates were made using a sterile glass tube (7 mm diameter) 
and filled with 70 μL of extract, with each extract tested in triplicate. Plates were dried in a laminar 
flow cabinet. Control plates contained solvent only (100% or 30% ethanol) and had no effect on the 
growth of any of the test bacteria. Once the plates were dry (no solvent present in the wells) they  
were spread inoculated with 24 h cultures of each of the test bacteria (grown in Marine Broth) and 
incubated at 27 °C for 48 h, after which the presence or absence of zones of inhibition, or stimulation 
of growth around wells, were recorded. Using this method it was apparent that there was very little 
activity of the hydrophilic extracts. Therefore, while the complete set (20 cyanobacteria × 26 bacteria 
in triplicate = 1560 assays) of cyanobacteria/bacteria combinations was tested for the lipophilic 
extracts, only nine of the 10 BBD cyanobacteria and seven of the 10 other marine cyanobacteria, were 
tested (1104 assays). All three known pathogens were also tested. All tests were performed in triplicate. 
4.6. Statistical Analysis 
To test for statistical significance of results, the percentages of inhibition of bacterial test strains by 
each cyanobacterial strain were first transformed to arcsin values. T-tests were used when the data 
passed both a Kolmogorov-Smirnov test for normality and a test for equal variance. If they failed a 
Mann-Whitney Rank Sum test was used. Statistical software used was SigmaStat ver. 3.5 (Systat 
Software, Inc.). 
5. Conclusions 
Marine environments, including tropical and sub-tropical coral reefs, have served as a source for 
novel natural products for decades. It may be that corals, and in particular their associated 
microorganisms, are a potential new source for antibacterials and other metabolites that could serve as 
biomedical agents with relevance to human health in a manner similar to bioactive compounds derived 
from marine sponges. In this study we have shown that cyanobacteria associated with a coral disease, 
and also non-pathogenic cyanobacteria from different sub-tropical marine environments, produce 
bioactive compounds that suppress the growth of coral-associated bacteria. These results supplement 
our earlier work that has shown that coral reef cyanobacteria produce the cyanotoxin microcystin. In 
terms of the microbial ecology of coral disease, specifically the subject of our study, black band Mar. Drugs 2011, 9  
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disease, it appears that the cyanobacteria that dominate BBD lesions have an active roll in disease 
etiology based on production of the cyanotoxin microcystin, which can cause coral tissue lysis [35], 
and antibacterial agents that target bacteria both within the complex BBD polymicrobial disease 
consortium and within the protective SML of healthy coral colonies. Thus cyanobacterial toxin and 
antibacterial production appear to be integral parts of the pathobiology of this coral disease.  
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